Ziprasidone
- Product NDC
- 68382-237
- 11-digit product format
- 683820237
- Labeler code
- 68382
- Product ID
- 68382-237_67a3abcb-44f4-46f8-8ebd-c28ac182bbd2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ziprasidone
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Application
- ANDA208988
- Marketing category
- ANDA
- Marketing start
- 2017-12-28
- Marketing end
- 0000-00-00
- Substance
- ZIPRASIDONE HYDROCHLORIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68382-237-05 | 68382023705 | 500 CAPSULE in 1 BOTTLE (68382-237-05) | 500 capsule | 2017-12-28 | 0000-00-00 | No | No | Current |
| 68382-237-14 | 68382023714 | 60 CAPSULE in 1 BOTTLE (68382-237-14) | 60 capsule | 2017-12-28 | 0000-00-00 | No | No | Current |
| 68382-237-80 | 68382023780 | 8 BLISTER PACK in 1 CARTON (68382-237-80) > 10 CAPSULE in 1 BLISTER PACK (68382-237-30) | 8 blister pack | 2017-12-28 | 0000-00-00 | No | No | Current |